El.En. S.p.A. (IT:ELN)
:ELN
Want to see IT:ELN full AI Analyst Report?
Top Page
El.En. S.p.A.
(ELN)
Select Model
Select Model
Rating:75Outperform
Price Target:
€19.00
▲(38.38% Upside)
Action:Upgraded
Date:06/10/26
The score is driven primarily by solid overall financial health—especially a conservative, improving balance sheet and recently recovered free cash flow—offset by recent margin compression and historical cash-flow volatility. Technicals add meaningful support with a strong uptrend and positive momentum, while valuation is fair with only a modest dividend yield.
Positive Factors
Conservative Balance Sheet
Very low leverage and rising equity give El.En. durable financial flexibility. A debt-to-equity near 0.09 limits financial strain in downturns, supports investment in R&D and capex, and reduces refinancing risk—strengths that matter over multiple quarters.
Negative Factors
Gross-Margin Compression
Material gross-margin deterioration in 2025 suggests pressure from product mix shifts, pricing, or cost inflation. If sustained, margin compression will erode cash generation and return on capital, forcing tougher trade-offs in pricing, R&D, or cost structure.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative Balance Sheet
Very low leverage and rising equity give El.En. durable financial flexibility. A debt-to-equity near 0.09 limits financial strain in downturns, supports investment in R&D and capex, and reduces refinancing risk—strengths that matter over multiple quarters.
Read all positive factors
El.En. S.p.A. (ELN) vs. iShares MSCI Italy ETF (EWI)
Market Cap
€1.32B
Dividend Yield1.58%
Average Volume (3M)100.73K
Price to Earnings (P/E)19.5
Beta (1Y)1.02
Revenue Growth4.42%
EPS Growth-16.04%
CountryIT
Employees2,080
SectorGeneral
Sector StrengthN/A
IndustryMedical - Devices
Share Statistics
EPS (TTM)0.74
Shares Outstanding80,384,550
10 Day Avg. Volume100,375
30 Day Avg. Volume100,726
Financial Highlights & Ratios
PEG Ratio-1.64
Price to Book (P/B)2.71
Price to Sales (P/S)1.89
P/FCF Ratio18.56
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€17.17Price Target Upside25.03% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)0.75
Revenue Forecast (FY)€626.68M
El.En. S.p.A. Business Overview & Revenue Model
Company Description
EL.En. S.p.A. is a global leader in the development, manufacturing, marketing, and distribution of advanced laser systems. The company supplies a wide array of medical laser equipment for applications in physiotherapy, orthopedics, traumatology, r...
How the Company Makes Money
El.En. makes money mainly by selling laser equipment and associated solutions to customers in its medical and industrial markets, complemented by recurring and service-related revenues tied to the installed base.
1) Equipment and system sales (pr...
El.En. S.p.A. Financial Statement Overview
Summary
Income Statement
66
Positive
Balance Sheet
84
Very Positive
Cash Flow
62
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 590.85M | 565.85M | 692.29M | 673.58M | 571.40M |
| Gross Profit | 131.62M | 238.80M | 252.08M | 243.47M | 206.09M |
| EBITDA | 92.83M | 97.35M | 83.94M | 90.71M | 76.59M |
| Net Income | 43.41M | 51.61M | 48.24M | 55.11M | 45.44M |
Balance Sheet | |||||
| Total Assets | 627.88M | 740.72M | 719.21M | 735.89M | 650.69M |
| Cash, Cash Equivalents and Short-Term Investments | 211.44M | 157.49M | 135.36M | 165.13M | 182.45M |
| Total Debt | 38.07M | 46.72M | 73.63M | 82.92M | 60.50M |
| Total Liabilities | 200.41M | 329.92M | 343.75M | 379.25M | 362.99M |
| Stockholders Equity | 411.72M | 385.02M | 346.03M | 313.19M | 269.37M |
Cash Flow | |||||
| Free Cash Flow | 60.08M | 73.61M | -1.14M | -16.31M | 63.35M |
| Operating Cash Flow | 70.81M | 83.07M | 12.22M | 2.12M | 79.48M |
| Investing Cash Flow | -12.97M | 68.68K | -16.97M | -30.15M | -20.23M |
| Financing Cash Flow | -30.70M | -47.99M | -24.79M | 10.25M | -3.51M |
El.En. S.p.A. Technical Analysis
Positive
13.73
Price Trends
14.03
Positive
13.61
Positive
12.82
Positive
Market Momentum
0.76
Negative
68.59
Neutral
72.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IT:ELN, the sentiment is Positive. The current price of 13.73 is below the 20-day moving average (MA) of 15.50, below the 50-day MA of 14.03, and above the 200-day MA of 12.82, indicating a bullish trend. The MACD of 0.76 indicates Negative momentum. The RSI at 68.59 is Neutral, neither overbought nor oversold. The STOCH value of 72.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IT:ELN.
El.En. S.p.A. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | €10.48B | 21.98 | 21.26% | 2.67% | 9.87% | 13.63% | |
75 Outperform | €1.32B | 19.53 | 15.29% | 1.58% | 4.42% | -16.04% | |
67 Neutral | €3.59B | 19.06 | 12.16% | 1.80% | 0.81% | -15.40% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
51 Neutral | €410.17M | 25.41 | ― | 5.24% | 6.80% | -84.47% |
* General Sector Average
IT:ELN
El.En. S.p.A.
16.46
5.94
56.43%
IT:DIA
DiaSorin S.p.A.
66.50
-25.75
-27.91%
IT:REC
Recordati Industria Chimica e Farmaceutica SPA
50.80
-2.48
-4.65%
IT:GHC
Garofalo Health Care S.P.A.
5.36
0.31
6.16%
IT:GPI
GPI SpA
14.24
3.91
37.85%
IT:IMD
I.M.D. International Medical Devices S.P.A.
1.34
0.03
1.90%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.